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Abstract
Neuronal positioning is a fundamental process during brain development. Abnormalities in this process cause several
types of brain malformations and are linked to neurodevelopmental disorders such as autism, intellectual disability,
epilepsy, and schizophrenia. Little is known about the pathogenesis of developmental brain malformations associated
with abnormal neuron positioning, which has hindered research into potential treatments. However, recent advances
in neurogenetics provide clues to the pathogenesis of aberrant neuronal positioning by identifying causative genes.
This may help us form a foundation upon which therapeutic tools can be developed. In this review, we first provide a
brief overview of neural development and migration, as they relate to defects in neuronal positioning. We then discuss
recent progress in identifying genes and brain malformations associated with aberrant neuronal positioning during
human brain development.
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Background
Neuronal positioning is an integral part of the coordi-
nated steps comprising neural circuit formation in em-
bryonic and neonatal development [1]. This process
takes place throughout the nervous system at different
time points depending on the type of neuron. Although
neuronal positioning and migration occurs throughout
the central nervous system, we will focus on neuronal po-
sitioning in the neocortex of the developing brain. We will
present basic information on the process of neuronal posi-
tioning and describe the abnormalities that may occur in
the human brain. Additionally, genes associated with
neuronal positioning abnormalities will be discussed.
Correct positioning of neurons by normal migration
plays a critical role in establishing cognitive functions and
emotion. Human cognitive activity depends on appropri-
ate brain circuit formation. Disrupted brain wiring due to
abnormal neuronal development such as improper neur-
onal positioning can result in brain malformations, cogni-
tive dysfunction, and seizures [2–4]. The causes of brain
malformations associated with positioning and migration
defects are varied and include genetic mutations and en-
vironmental toxins [1, 5, 6]. Studies of neuronal migration
disorders have progressed due to advances in molecular
genetics and brain magnetic resonance imaging. The com-
monly identified disorders of neuronal positioning include
lissencephaly and heterotopia [7].
Neural progenitors as a source of migrating
neurons in the human cerebral cortex
Neural progenitors can undergo self-renewal or give rise
to neurons at the ventricular/subventricular zone in the
developing cerebral cortex [8–10]. Reduced numbers of
neural progenitors caused by depletion of progenitor pools
or slow proliferation result in microcephaly with otherwise
normal brain structure [11, 12]. However, microcephaly
can also occur in combination with a migration defect,
i.e., microcephaly with pachygyria (Norman-Roberts syn-
drome) [13]. Thus, the disruptive functions of neural pro-
genitor renewal and neurogenesis may interfere with later
developmental aspects such as neuronal migration and
positioning in the developing brain.
Neuronal migration modes
After neurons are born, they migrate from their birth-
places to their final destinations (Fig. 1). There are two
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types of embryonic neuronal migration: radial and tan-
gential. The migration of excitatory pyramidal neurons
from the cortical ventricular zone (where they are born)
is an example of radial migration (Fig. 1a). These neu-
rons migrate into the cortical plate alongside radial glial
processes [14–17]. The layers of the cortex form in an
“inside-out” manner with later-born pyramidal neurons
migrating past earlier-born predecessors in the cortical
plate so that they are more superficial in their final pos-
ition than earlier born neurons [5, 18–20]. In humans,
neuronal migration takes place predominantly between
12 and 20 weeks in gestation. The migration of inhibi-
tory interneurons (GABAergic neurons) from the medial
ganglionic eminence of the ventral telencephalon (where
they are born) is an example of tangential migration
(Fig. 1b). Interneurons migrate tangentially to the dorsal
telencephalon and then change direction to enter the
cortical plate radially [20–23]. Subsets of these cells dis-
play ventricle-directed migration followed by radial
movement to the cortical plate. Thus, neuronal migra-
tion determines the positioning of developing neurons
into cortical layers and thereby is important in generat-
ing lamina-specific neural circuits. Normal development
and function of the neocortex critically depends on the
coordinated production and positioning of excitatory
and inhibitory neurons [24–27]. Abnormal neuronal mi-
gration can arrest different types of neurons at the
wrong positions along the migratory path resulting in
brain malformations and neurological disorders.
In addition to these well-defined modes of embryonic
neuronal migration, a limited number of neurons and

























Fig. 1 Two modes of neuronal migration in the developing brain. a Radial migration. Excitatory pyramidal projection neurons migrate from
the ventricular zone to the cortical plate in the developing brain. The right panel shows what happens in the rectangular box in the left panel.
Newly-born neurons from radial glial progenitors (RGP) at the ventricular zone (VZ) migrate along the radial processes of RGPs. MZ: marginal zone.
CP: cortical plate. IZ: intermediate zone. SVZ: subventricular zone. b Tangential migration: Interneurons originate from distinct proliferative
zones in the developing brain. Inhibitory interneurons are born in the medial ganglionic eminence (MGE) of ventral brain and migrate in
multiple streams into the cerebral wall. Once interneurons reach appropriate spots in the cerebral cortex, they establish their final positions
by local adjustment of radial and tangential movement. Unlike pyramidal neurons, these neurons extend multiple leading branches during
migration. LGE: lateral ganglionic eminence. LGE: lateral ganglionic eminence. Str: striatum
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Table 1 Brain malformations and genes associated with abnormal neuron positioning
Type Gene Location Description
Lissencephaly type I
Lissencephaly (Autosomal dominant) LIS1 17p13.3 Microtubule-associated protein
Isolated lissencephaly sequence (ILS) or subcortical band
heterotopia (SBH)
TUBA1A 12q13.12 Constituent of microtubules
Miller-Dieker syndrome LIS1 + YWHAE 17p13.3 Microtubule-associated protein
Lissencephaly (X-linked)
ILS or SBH DCX Xq22.3-
q23
Microtubule-associated protein
X-linked lissencephaly with abnormal genitalia ARX Xp21.3 Transcription factor
Lissencephaly (Autosomal recessive)
Lissencephaly with cerebellar hypoplasia (LCH) group b RELN 7q22 Extracellular matrix serine protease
VLDLR 9q24 Binds VLDL and transports it into cells by
endocytosis
Lissencephaly type II: Cobblestone complex (Autosomal recessive)
Fukuyama congenital muscular dystrophy or Walker–Warburg
syndrome (WWS)
FKTN 9q31.2 Involved in glycosylation
Muscle–eye–brain disease (MEB) or WWS POMT1 9q34.13 Protein-O-mannosyltransferase 1
POMT2 14q24.3 Protein-O-mannosyltransferase 2
POMGNT2 3p22.1 O-linked mannose acetylglucosaminyltransferase
FKRP 19q13.32 Involved in glycosylation
MEB LARGE 22q12.3 Glycosyltransferase
POMGnT1 1p34.1 Participates in O-mannosyl glycosylation
Bilateral frontoparietal polymicrogyria GPR56 16q21 G protein-coupled receptor 56
CEDNIK syndrome SNAP29 22q11.21 Synaptosomal-associated protein
Muscular dystrophy ISPD 7q21.2 Required for protein O-linked mannosylation
GTDC2 3p22.1 O-linked mannose acetylglucosaminyltransferase
TMEM5 12q14.2 Glycosyltransferase function
B3GALNT2 1q42.3 Beta-1,3-N-acetylgalactosaminyltransferase
SGK196 8q11.21 Protein O-mannose kinase
B3GNT1 11q13.2 Synthesis of the linear poly-N-
acetyllactosaminoglycans
GMPPB 3p21.31 GDP-mannose pyrophosphorylase
Polymicrogyria
TUBB2 6p25 Major constituent of microtubules
GPR56 16q21 G protein-coupled receptor 56
SRPX2 Xq22.1 Plays a role in angiogenesis
TBR2 3p24.1 Transcriptional activator
PAX6 11p13 Transcription factor
KIAA1279 10q22.1 Organization of axonal microtubules
RAB3GAP1 2q21.3 RAB3 GTPase Activating Protein Subunit
Adams-Oliver syndrome (AOS) ARHGAP31 3q13.33 Required for cell spreading
AOS RBPJ 4p15.2 Plays a central role in Notch signaling
AOS DOCK6 19p13.2 Atypical guanine nucleotide exchange factors
AOS EOGT 3p14.1 EGF domain-specific GlcNAc transferase
AOS NOTCH1 9q34.3 Play multiple roles during development
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differentiate in the early postnatal rodent and human
cerebellum and hypothalamus [28, 29]. Another, more
extensive mode of neuronal migration has been observed
in adult rodents and non-human primates, in which
neuronal precursors migrate along glial projections from
the subventricular zone into the olfactory bulbs. This
particular passage is referred to as the rostral migratory
stream (RMS) [28–30], which continues well into adult-
hood, but has not been observed in humans [28, 31]. In
the RMS, neuronal precursors migrate via a “tunnel”
made up of astrocytes into the olfactory bulb, where they
then radially migrate in a glial-independent manner to-
ward the glomeruli and differentiate. The majority of
these cells eventually become inhibitory neurons, mainly
GABAergic granule neurons [28, 32]. Because the appli-
cation of research tools is currently limited in humans,
there is still ongoing debate about whether the RMS ex-
ists in humans [28, 31, 32].
In this review we will focus solely on brain malformations
thought to be due to abnormal embryonic neuronal migra-
tion, although many of the genes and proteins discussed
are no doubt involved in both embryonic and postnatal
neuronal migration. It is important, however, that further
research be done to understand the mechanisms of
neuronal migration and the maintenance of neuronal pre-
cursor pools in adults, because of the potential to promote
regeneration and repair in individuals with neuronal posi-
tioning disorders, neurodegenerative disorders, and severe
brain injuries.Brain malformations and genes associated
with abnormal neuron positioning are listed in Table 1.
Genes and brain malformations associated with
defective neuron positioning
Type I lissencephaly
Perhaps the best known type of neuronal migration dis-
order is lissencephaly, “smooth brain”. It is a brain mal-
formation characterized by the absence of gyri and sulci
[7, 33]. Most individuals with this condition also present
with microcephaly (small head). Although the symptoms
vary, they often feature seizures, intellectual disability,
developmental delays, poor motor function, difficulties
with feeding, and swelling in the extremities.
Table 1 Brain malformations and genes associated with abnormal neuron positioning (Continued)
Heterotopia
Heterotopia (X-linked Autosomal dominant)
Classical bilateral periventricular heterotopia (PH) FLNA Xq28 Actin-binding protein
PH with fragile-X syndrome FMR1 Xq27.3 Translation repressor
PH and Williams syndrome WBSCR16 7q11.23 Guanine nucleotide exchange factor
PH PVNH3 5p15.1 Periventricular Nodular Heterotopia 3
PH PVNH5 5q14.3-
q15
Periventricular Nodular Heterotopia 5
Heterotopia (Autosomal recessive)
PH with microcephaly ARFGEF2 20q13.13 Intracellular vesicular trafficking
PH with Donnai–Barrow syndrome LRP2 2q31.1 Low density lipoprotein-related protein 2
Microcephaly
WDR62 19q13.12 Required for cerebral cortical development
KIAA1279 10q22.1 Organization of axonal microtubules
RAB3GAP1 2q21.3 RAB3 GTPase Activating Protein Subunit
ARFGEF2 20q13.13 Intracellular vesicular trafficking
Focal cortical dysplasia
TSC1 9q34.13 Negatively regulating mTORC signaling
TSC2 16p13.3 Negatively regulating mTORC signaling
Hemimegalencephaly
PIK3CA 3q26.32 Serine/threonine kinase - component of
PI3K/AKT signaling
AKT3 1q44 Serine/threonine kinase - component of
PI3K/AKT signaling
MTOR 1p36.22 Serine/threonine kinase – component of
PI3K/AKT signaling
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LIS1 and DCX
Mutations in lissencephaly 1 (LIS1) and doublecortin
(DCX) have been shown to cause type I lissencephaly
(Table 1). This disorder is often associated with axon
outgrowth and guidance defects such as agenesis of the
corpus callosum [34]. Neuronal positioning and further
differentiation may coordinate to develop the pathogen-
esis of lissencephaly. Classic lissencephaly (type I) in-
cludes isolated lissencephaly and subcortical band
heterotopia (“double cortex”) which are caused by DCX
mutations [33, 35]. In addition, heterozygous mutation
of Lis1 in mice has been shown to impair normal neuron
positioning and synaptogenesis in the amygdala [36].
Interestingly, there is a skewed sex ratio in subcortical
band heterotopia and isolated lissencephaly. Females
with a mutation affecting one copy of the DCX gene
usually develop subcortical band heterotopia while males
with one DCX gene mutation show isolated lissence-
phaly [37–41]. Males with subcortical band heterotopia
or females with isolated lissencephaly are rarely reported
[42, 43].
DCX encodes a microtubule-associated protein that
stabilizes microtubules and causes bundling [44–46].
This is an important molecule in neuron migration and
neurite growth in the developing brain [47–49]. DCX is
expressed in neuronal precursor cells and immature
neurons during brain development and in the adult
hippocampus. More importantly, DCX is associated
with the neuronal migration disorders, lissencephaly,
pachygyria, and subcortical band heterotopia [37, 38, 41,
50–52]. Mutations in DCX prevent neurons from mi-
grating into the cortical plate [45]. Abnormal micro-
tubule functions dependent on DCX appear to underlie
lissencephaly because pathological mutations in DCX
prevent its product binding and subsequent stabilization
of microtubules [53, 54].
Miller-Dieker syndrome is characterized as a congeni-
tal brain malformation due to the microdeletion of
chromosome 17p13.3 including the LIS1 gene, which
can also cause classical lissencephaly [37, 41, 51, 55–58].
LIS1 encodes a dynein-binding protein and controls mi-
totic spindle orientation in neural cells [59–61]. The
most common type of mutation is a deletion of a single
copy of the gene, resulting in haploinsufficiency. Individ-
uals with LIS1 mutations have not only lissencephaly,
but often show other pathological features including
corpus callosum hypoplasia and ventricle enlargement
[58, 62]. These anatomical abnormalities correlate with
the critical roles of LIS1 in neuronal migration and axon
formation [57, 58, 63]. In contrast to lissencephaly caused
by mutations in DCX, LIS1 mutations preferentially affect
the parieto-occipital cortex [37, 41, 64]. Mutations in LIS1
and DCX account for approximately 85% of patients with
the classic form of lissencephaly [37, 41, 65].
YWHAE
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase
Activation Protein, Epsilon (YWHAE) is another gene that
encodes a microtubule-associated protein and is located
just 1 Mb away from LIS1 on chromosome 17p. YWHAE
also participates in the LIS1 pathway, and homozygous de-
letion of mouse Ywhae leads to neuronal migration de-
fects. Large deletions of the 17p13.3 region (which
contains both YWHAE and LIS1) causes Miller-Dieker
syndrome, and patients with this deletion display more se-
vere neuronal migration defects than those observed in
LIS1mutant heterozygote-caused lissencephaly [54].
TUBA1A and TUBB2
Tubulin Alpha 1a (TUBA1A) and Tubulin Beta 2 (TUBB2)
encode critical structural subunits of microtubules that are
enriched during brain development [66]. TUBA1A muta-
tions are identified in 1 % of classic lissencephaly and 30%
of lissencephaly with cerebellar hypoplasia [67–69]. Mean-
while, TUBB2 mutations are associated with symmetric
polymicrogyria and pachygyria [70]. Guanosine triphos-
phate (GTP) contributes to microtubule assembly by bind-
ing to soluble tubulin heterodimers [71]. Mutations in
these tubulin genes prevent microtubule polymerization.
For example, the S140G mutation reduces the protein cap-
acities of GTP binding and native heterodimer formation,
thus preventing polymerization of microtubules and neur-
onal migration in mice [72]. In contrast to TUBA1A and
TUBB2, TUBB3 is important in axon guidance and
microtubule dynamics, but dispensable for neuronal
migration [73].
ARX
Aristaless related homeobox (ARX) is a homeobox-
containing gene expressed in the nervous system during
development [74–76]. ARX mutations are associated
with an X-linked lissencephaly syndrome with infantile
spasms as well as abnormal genitalia [77–79]. Mutations
that cause lissencephaly often lead to premature trunca-
tion or alter the DNA binding domain of the protein
(homeodomain) [80, 81]. Studies using human brain
samples and animal models have revealed that ARX is
important in proliferation of radial and intermediate
neural progenitors, and migration of excitatory cortical
neurons [75, 79, 80, 82]. It also critically controls the mi-
gration and further differentiation of inhibitory GABAergic
interneurons [79, 80, 82–86]. This is consistent with the
fact that ARX is expressed in the ganglionic eminence and
cortical ventricular zone where interneuron and pyramidal
neural progenitors reside, respectively [79]. Furthermore,
ARX overexpression promotes the development of tangen-
tially migrating interneurons [82, 86]. However, some
mutations disrupt neuronal excitability without affecting
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neuronal migration or the cortical lamination pattern in
the brain [87].
RELN
Reelin (RELN) and its cellular receptor very-low-
density-lipoprotein receptor (VLDLR) are cellular signal-
ing components. RELN is required for neuronal migra-
tion in the developing cortex [54, 88–91]. Accordingly,
VLDLR critically regulates neuronal migration and posi-
tioning in the cerebral cortex [92]. RELN promotes hip-
pocampal dendrite development through the VLDLR-
Dab1 pathway as well [93]. Mutations in these genes are
known to cause lissencephaly with cerebellar hypoplasia
[54, 94–96]. The RELN mutation syndrome appears to
be inherited in an autosomal-recessive pattern and these
patients appear to be relatively rare [94]. Mutations in
VLDLR can cause combinations of ataxia, intellectual
disability, and quadrupedal gait [97].
Type II lissencephaly
Type II lissencephaly is often referred to as “cobble-
stone lissencephaly” because patients typically only
have regional agyria. It is associated with Walker-
Warburg syndrome, a heterogeneous group of muscular
dystrophy-dystroglycanopathy (MDDG) conditions that
can be caused by homozygous mutations in the genes
FKTN (Fukuyama syndrome), POMT2 and POMGnT1
(muscle-eye-brain disease), as well as POMGNT2,
FKRP, LARGE, ISPD, GTDC2, TMEM5, B3GALNT2,
SGK196, B3GNT1, and GMPPB [98–101]. In type II lis-
sencephaly, there are no layers present in the cortex. In-
stead, irregularities in neuronal placement exist. Abnormal
glycosylation of matrix proteins in the cerebral cortex is
thought to cause these migration defects [102, 103].
Loss of function mutations in SNAP29, which encodes a
member of the SNARE protein family, has been shown to
cause CEDNIK (cerebral dysgenesis, neuropathy, ichthy-
osis and keratoderma) syndrome [104]. Brain MRI scans
of CEDNIK syndrome patients revealed apparent exten-
sive aberrant neuronal migration, as evidenced by corpus
callosum abnormalities and cortical dysplasia, along with
pachygyria, polymicrogyria and cobblestone lissencephaly
[105]. Migration defects in SNAP29 mutants may be at-
tributed to an impairment in β1-integrin [106].
Polymicrogyria
Polymicrogyria is a neurological condition characterized
by an excessive number of small and fused gyri sepa-
rated by shallow sulci in the cerebral cortex compared
to normal cerebral surfaces [6, 70, 107, 108]. Mutations
in the TUBB2, GPR56, and WDR62 genes are associated
with this condition [70, 109–111]. Polymicrogyria de-
velops between the late stage of neuronal migration
and the early point of cortical organization [108, 112].
Patients with polymicrogyria show a layer of intracortical
laminar necrosis and subsequent disruption of late cor-
tical lamination. Some cerebral cortices have a molecular
layer that does not align along the borders of gyri. Neu-
rons under this layer have a radial distribution without
laminar organization [111]. Polymicrogyria most often
occurs as an isolated feature. However, it is sometimes
shown in multiple genetic syndromes associated with in-
tellectual disability and birth defects including 22q11.2
deletion syndrome, Adams-Oliver syndrome (genetically
heterogeneous, caused by mutations in ARHGAP31,
RBPJ, DOCK6, EOGT, and NOTCH1), Aicardi syndrome,
Galloway-Mowat syndrome, Joubert syndrome, and
Zellweger spectrum (peroxisome biogenesis disorders in-
cluding Zellweger syndrome, neonatal adrenoleukodys-
trophy, and Refsum disease) [111, 113–116]. The clinical
features and etiology of polymicrogyria are heteroge-
neous. Most patients with polymicrogyria develop epi-
lepsy during their early childhood (4–12 years of age).
Seizures are resistant to pharmacological drugs in many
cases of polymicrogyria.
TBR2 and PAX6
Pax6, which encodes paired box protein 6, is highly
expressed in radial glia, but is downregulated as they
transition into intermediate progenitor cells during
neurogenesis. This coincides with an upregulation of T-
brain gene-2 (TBR2) that persists until intermediate
neural progenitor cells differentiate into postmitotic
neurons [117]. Mutations in TBR2 and PAX6 have been
shown to cause polymicrogyria, due to defects in neur-
onal migration, differentiation and proliferation of neural
progenitors [118–120].
SRPX2
SRPX2 encodes a secreted sushi-repeat containing pro-
tein that is expressed in neurons. A rare missense muta-
tion in the SRPX2 gene causes bilateral perisylvian
polymicrogyria, though its mechanism in development
of this disease remains unknown. SRPX2 is expressed in
humans in the fetal and adult brain, whereas in mice,
measurable expression does not begin until birth [121].
This poses problems for further studies into the role of
SRPX2 in brain development and neuronal migration.
KIAA1279
Homozygous nonsense mutations in the KIAA1279 gene
cause Goldberg-Shprintzen syndrome, which is charac-
terized by bilateral generalized polymicrogyria, micro-
cephaly, mental retardation, and an enteric nervous
disorder [122]. KIAA1279 encodes a kinesin family
member-binding protein, but its role in the pathology
of Goldberg-Shprintzen syndrome is still unknown [123,
124]. It was recently shown, however, that KIAA1279
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co-localizes with both α-tubulin and F-actin. Relatedly,
KIAA1279 is also involved in neurite outgrowth. Inhib-
ition of KIAA1279 expression using siRNA leads to den-
dritic spine depletion and a decrease in neurite length in
neuroblastoma cells, and overexpression of KIAA1279
triggers an increase in dendritic spine and neurite
length, compared to controls [123].
RAB3GAP
Rab3 GTPase-activating protein (RAB3GAP) is a hetero-
dimeric complex comprised of a catalytic subunit (RAB3-
GAP1) and a slightly larger non-catalytic subunit
(RAB3GAP2). This complex acts as a guanine-nucleotide
exchange factor for the RAB18 protein [125]. RAB18 is
also regulated by the GTP-activating protein TBC1D20
[126]. Mutations or dysregulation of RAB18 causes War-
burg Micro syndrome, which is characterized by ocular
and neurodevelopmental abnormalities, including polymi-
crogyria, microcephaly, pachygyria, polymicrogyria, and
hypoplasia of the corpus calossum. It is unclear by what
molecular mechanism RAB18 dysfunction leads to these
neurodevelopmental aberrations, but mutations to RAB3-
GAP1, RAB3GAP2, TBC1D20 and RAB18 are all sufficient
to cause these symptoms [125, 126]. It has recently been
demonstrated, that TBC1D20 activity fosters extraction of
RAB18 from the ER membrane and facilitates its retarget-
ing for the cis-Golgi. In the cis-Golgi, it appears that the
RAB3GAP complex recruits and stabilizes the RAB18
protein [126].
Heterotopia
In addition to cortical gyration disorder, dysfunctional
neuronal migration can lead to the development of neur-
onal population in aberrant locations. Periventricular
nodular heterotopia is one of these neuronal migration
disorders [5–7, 107, 108]. In this case, failed migration
leads to the formation of heterotopic neurons along the
ventricular surfaces in the brain. Therefore, the neurons
are positioned deeper than those found in type I lissen-
cephaly. This malformation can be bilateral or unilateral.
Periventricular heterotopia is diagnosed with magnetic
resonance imaging (MRI) and seizure symptoms. Affected
individuals usually have normal intelligence, although
some have mild intellectual disability. Some cases of peri-
ventricular heterotopia are associated with dyslexia [127].
For example, a specific reading fluency deficit is identified
in a heterogeneous group of patients with periventricular
heterotopia who have seizures, heterotopic neurons, and
disrupted cortical connectivity [127, 128].
FLNA
The most common genetic cause of periventricular het-
erotopia is the X-linked dominant inheritance of Filamin
A (FLNA) gene mutations [129, 130]. The FLNA gene
encodes an F-actin-binding cytoplasmic protein in-
volved in neurogenesis and neuronal migration in the
developing brain [131, 132]. FLNA crosslinks actin
filaments into the cortical cytoskeleton. FLNA muta-
tions are associated with classical bilateral periven-
tricular nodular heterotopia and account for the
majority of X-linked inherited periventricular hetero-
topias [6, 133, 134]. FLNA regulates neuronal migra-
tion in the cerebral cortex [131]. Mutations in the
human FLNA gene may also cause connective tissue
disorders associated with Ehlers-Danlos syndrome
which include extremely flexible joints, stretchable
skin, and fragile blood vessels [135]. Unsurprisingly,
patients with Ehlers-Danlos syndrome also frequently
present with epilepsy and periventricular heterotopia
[136].
PVNH3 and PVNH4
In addition to FLNA mutations, duplications and dele-
tions in chromosome 5 which includes Periventricular
Nodular Heterotopia 3 (PVNH3) and Periventricular
Nodular Heterotopia 5 (PVNH5) have been seen in pa-
tients with periventricular heterotopia without mutations
in other causative genes [137]. Periventricular nodular
heterotopia is also found in individuals with other condi-
tions, including Ehlers-Danlos syndrome [135].
FMR1
CGG trinucleotide repeat expansion of the FMR1 gene
causes fragile X syndrome in humans and has also been
shown to lead to periventricular heterotopia. This
may indicate a role for the FMR1 protein in neuronal
migration [138].
ARFGEF2
ADP-ribosylation factor guanine exchange factor 2
(ARFGEF2) encodes a protein kinase A-anchoring pro-
tein that regulates GDP-GTP conversion of ADP-
ribosylation factor [139, 140]. Via mediation of Filamin
A signaling, ARFGEF2 is involved in neuronal migra-
tion through the regulation of vesicle trafficking. Muta-
tions in ARFGEF2 also cause bilateral periventricular
nodular heterotopia, as well as putaminal hyperinten-
sity and microcephaly [131, 141].
LRP2
Low density lipoprotein-related protein 2 (LRP2) encodes
megalin, a multiligand receptor. Mutations to LRP2
cause Donnai-Barrow syndrome, which is associated
with several neurological and cranial abnormalities, in-
cluding periventricular nodular heterotopia [142]. Mega-
lin facilitates the endocytosis of sonic hedgehog (Shh) in
embryonic neuroepithelium [143]. Furthermore, megalin
has been shown to bind and sequester Shh in the
Moffat et al. Molecular Brain  (2015) 8:72 Page 7 of 12
forebrain, and mediate Shh-Ptch endocytosis [144]. This
key interaction with Shh signaling in the developing
brain could explain the aberrant neuronal positioning
observed in patients with LRP2 mutations.
Focal cortical dysplasia
Focal cortical dysplasia is a rare lamination abnormality
in the cerebral cortex characterized by focal cortical
thickening or thinning, focal atrophy, or blurring of the
gray-white junction [6, 145]. Focal cortical dysplasia is
the most common cause of medically refractory epilepsy
in the pediatric population [145]. Defective regulation of
neuronal migration or cell death is speculated to cause
focal cortical dysplasia [146, 147]. There are three types
of focal cortical dysplasia [34, 145, 148, 149]. Type I
focal cortical dysplasia is found in the temporal lobe of
the brain. This type is late onset, thus often seen in
adults. Patients with this condition show mild symp-
toms. Type II focal cortical dysplasia, however, is mostly
found in children and the clinical symptoms are more
severe. There are more extensive changes outside the
temporal lobe with predilection for the frontal lobes.
Type III focal cortical dysplasia occurs in combination
with hippocampal sclerosis, epilepsy-associated tumors,
vascular malformation, or epileptogenic lesions. Studies
have suggested that mutations in the TSC1 (Tuberous
Sclerosis 1) gene is associated with the formation of
focal dysplasia [145, 150, 151]. Changes in Wnt and
Notch signaling components that control proper
neuronal migration are also found in focal cortical dys-
plasia [145, 152].
Hemimegalencephaly
Hemimegalencephaly is implicated in neuronal posi-
tioning abnormality. Hemimegalencephaly features one
side of the brain that is abnormally larger than the
other [6, 108, 153]. The unusual enlargement of the
brain causes seizures and intellectual disability [154].
This condition is thought to take place when neurons
are abnormally organized due to defective migration in
the developing cerebral cortex because the enlarged hemi-
sphere usually shows focal or diffused regions of polymi-
crogyria, pachygyria, and heterotopia [155–159]. However,
whether abnormal neuronal migration during develop-
ment causes hemimegalencephaly is unclear. Using exome
sequencing, recent studies have identified de novo germ-
line and somatic mutations of PI3K-AKT-mTOR compo-
nents (PIK3CA, AKT3, and MTOR genes) in patients
with hemimegalencephaly [160–164]. Thus, hemimega-
lencephaly may be a genetically mosaic disease caused by
abnormal PI3K-AKT-mTOR signaling. In addition to its
role in neuronal migration, PI3K-AKT-mTOR signaling
critically regulates neural progenitor proliferation and
neurogenesis [32, 165–168].
Conclusions
Recent advances in neurogenetics and brain imaging
have revealed genes responsible for neuronal migration
disorders. Efforts have been made to characterize the
functions of the causative genes and develop appropriate
animal models. Still, research that overcomes these dis-
orders is only in the beginning stage of work. Further
human genetic analysis and neurobiological studies
should expand our understanding of the pathogenesis of
neuronal migration disorders, which will help to develop
therapeutic strategies for these disorders in the future.
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